Nuplazid 34 MG capsule 30S

Ended Awarded Last action

Contract number
SPE2DR26FHLB1
Awardee
Awarding agency
Obligated
$3,924

Award facts

Contract value 100% obligated
$3,923.82 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $3,923.82 delivery order to DMS Pharmaceutical Group Inc. on March 23, 2026, for Nuplazid 34 mg capsules under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V).

DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is Park Ridge, IL. The order is firm fixed price with an ultimate completion date of April 13, 2026. The delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with DLA, which carries a $499.999 billion ceiling and runs through December 31, 2036.

Quick answers

Who was awarded contract SPE2DR26FHLB1?

SPE2DR26FHLB1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on March 23, 2026.

How much is contract SPE2DR26FHLB1 worth?

The government has obligated $3,924 on SPE2DR26FHLB1.

Is contract SPE2DR26FHLB1 an order under another contract?

Yes. SPE2DR26FHLB1 is a delivery order under SPE2DR25D9222, an indefinite delivery contract.

Was contract SPE2DR26FHLB1 competed?

The extent of competition for SPE2DR26FHLB1 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award